Scilex Holding (SCLXW) Equity Ratio (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Equity Ratio of 0.87 in Q1 2026, down 51.99% quarter-over-quarter from 0.57 in Q4 2025, and up 67.69% on a YoY basis from 0.52 in Q1 2025.

Scilex Holding (SCLXW) Equity Ratio (2020 - 2026) Analysis & Trends

Scilex Holding's Equity Ratio history runs 7 years deep, the most recent figure standing at 0.87 for Q1 2026.

  • In Q1 2026, Equity Ratio rose 67.69% year-over-year to 0.87; the TTM figure through Mar 2026 stood at 0.87 (up 67.69% YoY), while the FY2025 annual figure was 0.57, up 72.53% from the prior year.
  • Equity Ratio was 0.87 for Q1 2026 at Scilex Holding, down from 0.57 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.42 in Q4 2022 to a low of 2.97 in Q2 2025.
  • Historically, Equity Ratio has averaged 1.46 across 5 years, with a median of 1.77 in 2022.
  • Biggest YoY gain for Equity Ratio was 114.58% in 2022; the steepest drop was 3111.89% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.42 in 2022, then tumbled by 507.58% to 1.71 in 2023, then retreated by 21.41% to 2.07 in 2024, then soared by 72.53% to 0.57 in 2025, then sank by 51.99% to 0.87 in 2026.
  • The last three Equity Ratio figures came in at 0.87 (Q1 2026), 0.57 (Q4 2025), and 0.64 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 0.27
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 0.40
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -0.05
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 0.36
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 0.10
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 0.42
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 0.43
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 0.23
10 Scilex Holding - - 4.15 Mn -0.87

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.87
Dec 31, 2025 -0.57
Sep 30, 2025 -0.64
Jun 30, 2025 -2.97
Mar 31, 2025 -2.68
Dec 31, 2024 -2.07
Sep 30, 2024 -2.10
Jun 30, 2024 -2.05
Mar 31, 2024 -2.08
Dec 31, 2023 -1.71
Sep 30, 2023 -2.02
Jun 30, 2023 0.08
Mar 31, 2023 0.13
Dec 31, 2022 0.42
Sep 30, 2022 -2.26
Jun 30, 2022 -1.77
Mar 31, 2022 -1.64
Dec 31, 2021 -2.87
Sep 30, 2021 -0.07
Jun 30, 2021 -0.06